CClinicalTrials.gg
CompletedNCT00932919Updated Apr 23, 2014

Thought Field Therapy and Cognitive Therapy for Agoraphobia

An interventional study of Thought field therapy and Cognitive therapy in Agoraphobia, sponsored by Sorlandet Hospital HF. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-04-23.

Sponsored by Sorlandet Hospital HF · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Read the detailed description

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

02

Conditions studied

  • Agoraphobia

Browse trials for

Keywords

  • Agoraphobia
  • Cognitive therapy
  • Thought field therapy
  • Psychotherapy research
03

In context

Agoraphobia

63 studies on the registry are indexed under Agoraphobia; 11 are open to participants now.

This study's enrollment of 72 is close to the median of 80 across 57 interventional studies indexed under Agoraphobia.

Browse Agoraphobia studies →

Lead sponsor

Sorlandet Hospital HF is the lead sponsor of 73 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients ages 18 years or older,
  • Patients with agoraphobia,
  • Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
  • Patients who give a written consent to participate.

Exclusion criteria

Exclusion Criteria:

  • Psychosis (past or present),
  • Drug abuse or dependency,
  • Moderate or high score on suicidal behaviour on the M.I.N.I.,
  • Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Thought field therapy

    24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy.

    Behavioral: Thought field therapy

  • Active comparator
    Cognitive therapy

    Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model.

    Behavioral: Cognitive therapy

  • Other
    Wait list

    24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy.

    Behavioral: Wait list

Interventions

  • BehavioralThought field therapy

    5 sessions with Thought field therapy

    Also known as: TFT

  • BehavioralCognitive therapy

    12 sessions of Cognitive therapy

    Also known as: CBT

  • BehavioralWait list

    3 months waiting, then randomized to either thought field therapy or cognitive therapy

    Also known as: WL

06

What researchers measure

Primary outcomes

  1. Change in agoraphobic situation scores in ADIS.

    Time frame: Immedeately and 12 months after treatment

Secondary outcomes

  1. Interference score in ADIS

    Time frame: Immediately and 12 months after treatment

  2. Mobility Inventory

    Time frame: Immediately and 12 months after treatment

  3. Agoraphobic Cognitions Questionnaire

    Time frame: Immediately and 12 months after treatment

  4. Body Sensations Questionnaire

    Time frame: Immediately and 12 months after treatment

  5. BDI

    Time frame: Immediately and 12 months after treatment

  6. BAI

    Time frame: Immediately and 12 months after treatment

  7. WHOQOL-BREF

    Time frame: Immediately and 12 months after treatment

  8. SF-36

    Time frame: Immediately and 12 months after treatment

  9. Safety Seeking Behaviours Questionnaire.

    Time frame: Immediately and 12 months after treatment

  10. Panic scale

    Time frame: Immediately and 12 months after treatment

07

Study locations

1 site
  • Sorlandet Hospital
    Arendal, 4809, Norway
08

References and documents

Publications

  • Irgens AC, Hoffart A, Nysaeter TE, Haaland VO, Borge FM, Pripp AH, Martinsen EW, Dammen T. Thought Field Therapy Compared to Cognitive Behavioral Therapy and Wait-List for Agoraphobia: A Randomized, Controlled Study with a 12-Month Follow-up. Front Psychol. 2017 Jun 20;8:1027. doi: 10.3389/fpsyg.2017.01027. eCollection 2017. PubMed 28676782 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00932919
Lead sponsor
Sorlandet Hospital HF
Responsible party
Sponsor
First posted
Jul 7, 2009
Start date
Oct 2006
Primary completion
Nov 2010
Completion
Nov 2010
Last update
Apr 23, 2014

Study contacts

Audun C Irgens, MD
principal investigator · Sorlandet Hospital HF, Norway

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion